Wave Life Sciences, Inc. (WVE) › Cash & EquivalentsWave Life Sciences, Inc. (WVE) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2012-12-31: $379.0K2013-12-31: $439.0K2014-12-31: $1.05M2015-12-31: $161.22M2016-12-31: $150.29M2017-12-31: $142.50M2018-12-31: $174.82M2019-12-31: $147.16M2020-12-31: $184.50M2021-12-31: $150.56M2022-12-31: $88.50M2023-12-31: $200.35M2024-12-31: $302.08M2025-12-31: $602.07M$602.07M2012-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$602.07M+99.3%2026-02-26Balance as of period end2024-12-31$302.08M+50.8%2026-02-26Balance as of period end2023-12-31$200.35M+126.4%2025-03-04Balance as of period end2022-12-31$88.50M-41.2%2024-03-06Balance as of period end2021-12-31$150.56M-18.4%2023-03-23Balance as of period end2020-12-31$184.50M+25.4%2022-03-03Balance as of period end2019-12-31$147.16M-15.8%2021-03-04Balance as of period end2018-12-31$174.82M+22.7%2020-03-02Balance as of period end2017-12-31$142.50M-5.2%2019-03-01Balance as of period end2016-12-31$150.29M-6.8%2018-03-12Balance as of period end2015-12-31$161.22M+15283.6%2018-03-12Balance as of period end2014-12-31$1.05M+138.7%2018-03-12Balance as of period end2013-12-31$439.0K+15.8%2017-03-16Balance as of period end2012-12-31$379.0K—2016-03-30Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)